{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/parkinsons-disease/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"58a49a4b-fb27-55f3-9afb-3c816842a76a","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field d7049c5d-03fc-477b-85b4-e2d5357e7517 --><h2>How common is it?</h2><!-- end field d7049c5d-03fc-477b-85b4-e2d5357e7517 -->","summary":"","htmlStringContent":"<!-- begin item 5f6487bd-4611-47f2-8961-5ac46a80c6cb --><!-- begin field 39db3679-8c16-4039-ae7d-b47d83f73f09 --><ul><li><strong>Parkinson's disease is a common condition in elderly people. </strong><ul><li>A Parkinson's UK report of the Clinical Practice Research Datalink (CPRD) using primary care data from 2015 found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">Parkinson&#39;s UK, 2018</a>]:<ul><li>There were about 137,000 people living with Parkinson’s disease in the UK.</li><li>The prevalence rate was 286.5 per 100,000 person years.</li><li>The incidence rate was 33.4 per 100,000 person years, and each year there are about 17,300 new diagnoses of Parkinson’s disease in people aged 45 years and above.</li><li>The prevalence of Parkinson's disease increases with age — the prevalence is 4–5 per 100,000 people in people aged 30–39 years, compared with 1,696 per 100,000 people aged 80–84 years (equivalent to 1.7% of this age group).</li><li>Prevalence rates almost double every five year interval between 50–69 years for both men and women.</li><li>The prevalence is higher in men than in women — prevalence rates for men aged 50–89 years were more than 1.5 times higher than rates for women in the same age group. This equates to 22 in every 10,000 women and 32 in every 10,000 men have been diagnosed with Parkinson’s disease.</li><li>The lifetime risk of being diagnosed with Parkinson’s disease is 2.7%. This is equivalent to 1 in every 37 people being diagnosed at some point in their lifetime.</li><li>By 2025, because of population growth and an increasingly ageing population, the estimated prevalence of Parkinson’s disease is expected to increase by 23.2%, and the estimated yearly incidence is expected to increase by 23.9%.</li></ul></li><li>A GP with an average list size of about 1,500 patients will only see one new case of Parkinson's disease every 3.3 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">SIGN, 2010</a>].</li></ul></li></ul><!-- end field 39db3679-8c16-4039-ae7d-b47d83f73f09 --><!-- end item 5f6487bd-4611-47f2-8961-5ac46a80c6cb -->","topic":{"id":"6cfe5031-c78a-5fcf-8597-8688ef0d3a41","topicId":"ac61656d-8e8b-48b8-bf1d-49f506afadb6","topicName":"Parkinson's disease","slug":"parkinsons-disease","lastRevised":"Last revised in February 2018","chapters":[{"id":"8bebf6b8-3a72-530a-ac48-52a8618f2267","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"044ab1d2-584c-5ed9-ab24-f7c8d64ef959","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"51b4e173-4f8a-5f7a-9e4a-fff68f32b031","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"29a7b8ce-d32b-5e9d-a682-56084e34b727","slug":"changes","fullItemName":"Changes"},{"id":"e1bb005f-8b49-5ae3-9670-a888d5def19a","slug":"update","fullItemName":"Update"}]},{"id":"fbbb2e6c-5309-5aa6-a27f-d6f508b6f994","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"40c62f24-40c5-5619-88aa-963a7de0d17d","slug":"goals","fullItemName":"Goals"},{"id":"2b0ddbc1-3535-545a-8be3-996ce778ee4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a8f322a5-4ac1-50c9-8391-83584bd86b30","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d2a1f92e-43cd-575e-bcbd-7bd0e6792634","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e860c3e6-3288-5ee1-bd77-a6d4aa0c3006","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d3463e24-bbaa-5d3a-aca9-0d6da87a47f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"644e166b-8434-55a7-859c-6479b609051a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"935e4ed2-12f3-5857-9a26-8a3beaed429c","slug":"definition","fullItemName":"Definition"},{"id":"58a49a4b-fb27-55f3-9afb-3c816842a76a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ce592a68-6b1f-5015-8125-2facfdcc4afe","slug":"prognosis","fullItemName":"Prognosis"},{"id":"8a05334f-9e7a-5662-b166-d86bd3c7546e","slug":"complications","fullItemName":"Complications"}]},{"id":"3951c9c0-49fe-5d17-8d1d-4c42b0b95c3f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7662ffa-e42d-5bb5-9025-2ba5f6587a6f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"435dc95c-73c1-5636-953b-feb3d7f82aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"196d12bb-51bd-5a0b-872d-c7b60bde431b","fullItemName":"Management","slug":"management","subChapters":[{"id":"38b7e750-e77e-5791-a127-6e5192b69597","slug":"suspected-parkinsons-disease","fullItemName":"Scenario: Suspected Parkinson's disease"},{"id":"fae10e1b-26bc-523c-bc3b-ec45e56860ca","slug":"confirmed-parkinsons-disease","fullItemName":"Scenario: Confirmed Parkinson's disease"},{"id":"c0adefb6-a71d-5b3c-bc2d-b86a13219e16","slug":"end-stage-parkinsons-disease","fullItemName":"Scenario: End-stage Parkinson's disease"}]},{"id":"d811822d-b022-5b69-8514-00e15d349643","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"83038956-9818-52c8-9415-85ab073e43aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"757d939c-8a84-5a32-847b-38d850b38230","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17a6cb12-1c93-5aff-bc74-2c2cee2f97ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bd851d10-0cce-5204-8b2e-54ae60c5767f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9d232b23-7764-59d5-8026-50fff91a905b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7deed303-b70d-5459-8ca1-d40e9dbf3c88","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1a717fd3-80b2-587f-8d46-3f904380d76a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"644e166b-8434-55a7-859c-6479b609051a","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}